These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 33763903)

  • 1. Nondermatophyte mould onychomycosis.
    Gupta AK; Summerbell RC; Venkataraman M; Quinlan EM
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):1628-1641. PubMed ID: 33763903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature.
    Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC
    J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive review of nondermatophyte mould onychomycosis: Epidemiology, diagnosis and management.
    Gupta AK; Wang T; Cooper EA; Summerbell RC; Piguet V; Tosti A; Piraccini BM
    J Eur Acad Dermatol Venereol; 2024 Mar; 38(3):480-495. PubMed ID: 38010049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, comparative study on efficacy and safety of itraconazole pulse therapy and terbinafine pulse therapy on nondermatophyte mold onychomycosis: A study with 90 patients.
    Ranawaka RR; Nagahawatte A; Gunasekara TA; Weerakoon HS; de Silva SH
    J Dermatolog Treat; 2016 Aug; 27(4):364-72. PubMed ID: 26651495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Onychocola canadensis Sigler in onychomycosis : A new dermatophyte-like mould in Germany].
    Nenoff P; Schorlemmer B; Uhrlaß S; Baunacke A; Baunacke A; Friedrichs C; Iffländer J; Syhre E; Schneider A; Krüger C; Maier T
    Hautarzt; 2016 Sep; 67(9):739-49. PubMed ID: 26758910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous terbinafine and pulse itraconazole for the treatment of non-dermatophyte mold toenail onychomycosis.
    Shemer A; Gupta AK; Kamshov S; Babaev M; Hermush V; Farhi R; Daniel CR; Foley KA
    J Dermatolog Treat; 2021 May; 32(3):310-313. PubMed ID: 31415182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.
    Gupta AK; Shear NH
    Drug Saf; 2000 Jan; 22(1):33-52. PubMed ID: 10647975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients.
    De Doncker PR; Scher RK; Baran RL; Decroix J; Degreef HJ; Roseeuw DI; Havu V; Rosen T; Gupta AK; Piérard GE
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):173-7. PubMed ID: 9039163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment.
    Gupta AK; Drummond-Main C; Cooper EA; Brintnell W; Piraccini BM; Tosti A
    J Am Acad Dermatol; 2012 Mar; 66(3):494-502. PubMed ID: 21820203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of non dermatophyte onychomycosis ant its relevance for treatment].
    Monod M; Lurati M; Baudraz-Rosselet F
    Rev Med Suisse; 2013 Apr; 9(380):730-3. PubMed ID: 23621043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis.
    Mishra M; Panda P; Tripathy S; Sengupta S; Mishra K
    Indian J Dermatol Venereol Leprol; 2005; 71(4):262-6. PubMed ID: 16394436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of antifungal agents in onychomycoses.
    Debruyne D; Coquerel A
    Clin Pharmacokinet; 2001; 40(6):441-72. PubMed ID: 11475469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacious treatment of non-dermatophyte mould onychomycosis with topical amphotericin B.
    Lurati M; Baudraz-Rosselet F; Vernez M; Spring P; Bontems O; Fratti M; Monod M
    Dermatology; 2011; 223(4):289-92. PubMed ID: 22236569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of resistant onychomycosis with voriconazole in a liver transplant patient.
    Nofal A; Fawzy MM; El-Hawary EE
    Dermatol Ther; 2020 Nov; 33(6):e14014. PubMed ID: 32667111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
    Jo Siu WJ; Tatsumi Y; Senda H; Pillai R; Nakamura T; Sone D; Fothergill A
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1610-6. PubMed ID: 23318803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onychomycosis: a review.
    Gupta AK; Stec N; Summerbell RC; Shear NH; Piguet V; Tosti A; Piraccini BM
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):1972-1990. PubMed ID: 32239567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
    Ranawaka RR; Nagahawatte A; Gunasekara TA
    Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onychomycosis: modern diagnostic and treatment approaches.
    Tchernev G; Penev PK; Nenoff P; Zisova LG; Cardoso JC; Taneva T; Ginter-Hanselmayer G; Ananiev J; Gulubova M; Hristova R; Nocheva D; Guarneri C; Martino G; Kanazawa N
    Wien Med Wochenschr; 2013 Jan; 163(1-2):1-12. PubMed ID: 23053563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antifungal susceptibility testing of fungi in patients with onychomycosis.
    Abu El-Hamd M; Abd Elhameed MI; Shalaby MFM; Saleh R
    Dermatol Ther; 2020 May; 33(3):e13429. PubMed ID: 32304603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.